Rabivas-20
RABIVAS-20 is a proton pump inhibitor (PPI) that effectively reduces gastric acid secretion. It is commonly used for the treatment of acid-related gastrointestinal disorders, offering relief from symptoms such as heartburn, acid reflux, and indigestion.
- Recommended Usage
Indications
- Gastroesophageal Reflux Disease (GERD): Provides relief from acid reflux and heartburn.
- Peptic Ulcers: Promotes healing of stomach and duodenal ulcers.
- Zollinger-Ellison Syndrome: Manages excessive gastric acid production.
- Erosive Esophagitis: Treats inflammation of the esophagus caused by acid reflux.
- NSAID-Induced Gastric Damage: Protects the stomach lining in patients on long-term NSAID therapy.
Dosage and Administration
Route of Administration: Oral tablet.
Typical Dose for Adults: One tablet (20mg) daily before meals, or as directed by a healthcare provider.
Administration: Swallow the tablet whole with water. Do not crush, chew, or split the tablet.
Precautions
Hypersensitivity: Avoid use in patients allergic to rabeprazole or other PPIs.
Long-Term Use: Prolonged use may increase the risk of bone fractures, magnesium deficiency, and vitamin B12 deficiency. Regular monitoring is advised.
Pregnancy and Breastfeeding: Use only under medical supervision.
Drug Interactions: May reduce the effectiveness of drugs requiring acidic pH for absorption (e.g., ketoconazole, itraconazole).
Renal or Hepatic Impairment: Use cautiously and under medical advice in patients with severe kidney or liver disease.
Benefits
Effective Acid Suppression: Reduces gastric acid secretion for lasting relief from GERD and ulcers.
Promotes Healing: Accelerates the recovery of damaged stomach and esophageal tissues.
Once-Daily Convenience: Provides 24-hour symptom control with a single daily dose.
Protects Against NSAID Damage: Prevents gastric irritation and ulcers associated with NSAID use.
Well-Tolerated: Minimal side effects when taken as prescribed.
